|
|
Office Locations:
|
One Penn Plaza, Suite 2705
New York, NY 10119
Phone: 212-393-4790
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Regal is a private equity fund exclusively focused on healthcare services. The firm seeks to partner with leading entrepreneurs in fragmented sectors of healthcare where Regal can provide a combination of operational expertise and financial backing to accelerate growth. Regal targets companies with 10M - $50M in revenues, and $2M - $7M EBITDA. Regal closed Fund II in less than two and a half months, and surpassed its initial target of $125 million. This Fund will continue Regal's strategy of partnering with leading entrepreneurs in the healthcare services space. Together with Regal's first fund, which was raised in February 2018, Regal now manages a total committed capital base of over $250 million. Regal targets equity investments of $10 - $30 million in each opportunity.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
